FDA Inspection 1198028 — Kentucky Blood Center Inc
The FDA completed an inspection of Kentucky Blood Center Inc on February 17, 2023 in Louisville, KY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 17, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Louisville, KY (United States)